Endocrinology News

SAN DIEGO — Glucagon-like peptide-1 receptor agonists may help alleviate risk for adverse liver outcomes, particularly hepatic decompensation, among patients with type 2 diabetes and alcohol-associated liver disease.

CHICAGO — Exenatide, an IV GLP-1 receptor agonist, did not improve clinical outcomes compared with placebo in patients undergoing heart surgery, according to the results of the GLORIOUS trial.

CHICAGO — An intensive blood pressure strategy resulted in a lower incidence of major cardiovascular events compared with a more standard strategy among patients with type 2 diabetes and elevated systolic blood pressure in the BPROAD trial.

CHICAGO — In adults with HF with preserved ejection fraction and obesity, treatment with tirzepatide cut risk for CV death or worsening HF by 38% compared with placebo, with a parallel improvement in health status and exercise tolerance.

Genetic variants found in hidradenitis suppurativa may be correlated to genetic variants in coronary artery disease and diabetes, according to a study.

CHICAGO — An AI-enabled tool utilizing machine learning, high-speed images and video accurately detected hypertension and type 2 diabetes among Japanese adults compared with continuous BP monitoring and HbA1c testing, researchers reported.

In this video exclusive, Deidra C. Crews, MD, ScM, FASN, president of the American Society of Nephrology discusses connections between kidney disease and obesity.

The prevalence of obesity in the U.S. more than doubled from 1990 to 2021, and the number of Americans with obesity could reach 260 million by 2050 if trends do not change, researchers reported in The Lancet.

Why not just invest in one stock and let it ride? That works well if you bet the farm on Apple in 2010 and watched your fortune explode 30 time during the last 14 years.

From 1990 to 2022, diabetes prevalence rose greatly, but for the most part, treatment did not increase at all or sufficiently, especially in low- and middle-income countries, researchers reported in The Lancet.